Niranjan Konduri is Deputy Technical Director for the Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program. With expertise in cross-cutting access to medicines initiatives and pharmaceutical systems strengthening activities Konduri provides strategic oversight in the design, implementation, and monitoring of the Global Health Security Agenda action package on antimicrobial resistance, infection prevention and control, and multisectoral stakeholder coordination.

Konduri served as an advisory member in the Harvard Global Equity Initiative’s Global Task Force on Expanded Access to Cancer Care and Control, and co-developed a framework on access to affordable medicines, vaccines, and health technologies for cancer, which was subsequently published by Harvard University Press. He was invited to speak at the 16th United States-Africa Growth Opportunity Act Forum, co-chaired by the US Department of the Treasury, where he advocated for medical product regulatory systems strengthening initiatives to address the growing burden of non-communicable diseases.  

Konduri represented MSH at the World Health Organization’s high-level Task Force for New Drug Policy Development, which resulted in a vetted tool kit for a new tuberculosis (TB) medicine policy implementation package. He has also led teams in publishing results and policy recommendations from various public and private sector pharmaceutical systems activities that were featured or cited in Forbes, Devex, WHO, Lancet Global Health, and India Spend, a data journalism initiative. Konduri holds an M.S. in pharmacoeconomics, epidemiology, pharmaceutical policy, and outcomes research and an MPH in global health. Prior to joining MSH, he worked with IQVIA in India, providing consulting services to pharmaceutical companies in market research and prescription audits.